Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jingyang Li

Showing results (141-150 of 166) with videos related to

Pageof 17
Sort By:
Rheumatology and Therapy|May 9, 2025
Efficacy of Ixekizumab in Chinese Patients with Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein LevelNing Kong, Jiankang Hu, Dongzhou Liu, et al.
Rheumatology and Therapy|January 6, 2026
Efficacy of Ixekizumab in Chinese Patients with Radiographic-Axial Spondyloarthritis by Baseline Inflammation Status on Magnetic Resonance ImagingXiaoxia Zhu, Jiankang Hu, Dongzhou Liu, et al.
Rheumatology and Therapy|June 21, 2024
Rapid and Sustained Effect of Ixekizumab on Patient Global, Spinal Pain, Stiffness, and Fatigue in Chinese Patients with Radiographic Axial SpondyloarthritisXiaoxia Zhu, Jiankang Hu, Dongzhou Liu, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 22, 2023
Ixekizumab for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 52-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled StudyYu Xue, Jiankang Hu, Dongzhou Liu, et al.
The Lancet Regional Health. Western Pacific|February 15, 2024
Safety and efficacy of peficitinib in Asian patients with rheumatoid arthritis who had an inadequate response or intolerance to methotrexate: results of a multicenter, randomized, double-blind, placebo-controlled phase 3 studyYue Yang, Jingyang Li, Ju Liu, et al.
Parasitology|February 13, 2020
Production and characterization of monoclonal antibodies against <i>Toxoplasma gondii</i> ROP18 with strain-specific reactivityFamin Zhang, Rui Su, Chengjian Han, et al.
Plant Physiology and Biochemistry : PPB|April 12, 2024
Role of calcium nutrition in plant Physiology: Advances in research and insights into acidic soil conditions - A comprehensive reviewTao Jing, Jingyang Li, Yingdui He, et al.
Nature Structural & Molecular Biology|April 22, 2024
Transcription directionality is licensed by Integrator at active human promotersJiao Yang, Jingyang Li, Langxi Miao, et al.
Veterinary Research|July 29, 2024
Baicalin attenuates PD-1/PD-L1 axis-induced immunosuppression in piglets challenged with Glaesserella parasuis by inhibiting the PI3K/Akt/mTOR and RAS/MEK/ERK signalling pathwaysShulin Fu, Jingyang Li, Jiarui You, et al.
Veterinary Research|October 1, 2024
Correction: Baicalin attenuates PD-1/PD-L1 axis-induced immunosuppression in piglets challenged with Glaesserella parasuis by inhibiting the PI3K/ Akt/mTOR and RAS/MEK/ERK signalling pathwaysShulin Fu, Jingyang Li, Jiarui You, et al.
Pageof 17

Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
Rheumatology and Therapy|May 9, 2025
Efficacy of Ixekizumab in Chinese Patients with Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein LevelNing Kong, Jiankang Hu, Dongzhou Liu, et al.
Rheumatology and Therapy|January 6, 2026
Efficacy of Ixekizumab in Chinese Patients with Radiographic-Axial Spondyloarthritis by Baseline Inflammation Status on Magnetic Resonance ImagingXiaoxia Zhu, Jiankang Hu, Dongzhou Liu, et al.
Rheumatology and Therapy|June 21, 2024
Rapid and Sustained Effect of Ixekizumab on Patient Global, Spinal Pain, Stiffness, and Fatigue in Chinese Patients with Radiographic Axial SpondyloarthritisXiaoxia Zhu, Jiankang Hu, Dongzhou Liu, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 22, 2023
Ixekizumab for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 52-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled StudyYu Xue, Jiankang Hu, Dongzhou Liu, et al.
The Lancet Regional Health. Western Pacific|February 15, 2024
Safety and efficacy of peficitinib in Asian patients with rheumatoid arthritis who had an inadequate response or intolerance to methotrexate: results of a multicenter, randomized, double-blind, placebo-controlled phase 3 studyYue Yang, Jingyang Li, Ju Liu, et al.
Parasitology|February 13, 2020
Production and characterization of monoclonal antibodies against <i>Toxoplasma gondii</i> ROP18 with strain-specific reactivityFamin Zhang, Rui Su, Chengjian Han, et al.
Plant Physiology and Biochemistry : PPB|April 12, 2024
Role of calcium nutrition in plant Physiology: Advances in research and insights into acidic soil conditions - A comprehensive reviewTao Jing, Jingyang Li, Yingdui He, et al.
Nature Structural & Molecular Biology|April 22, 2024
Transcription directionality is licensed by Integrator at active human promotersJiao Yang, Jingyang Li, Langxi Miao, et al.
Veterinary Research|July 29, 2024
Baicalin attenuates PD-1/PD-L1 axis-induced immunosuppression in piglets challenged with Glaesserella parasuis by inhibiting the PI3K/Akt/mTOR and RAS/MEK/ERK signalling pathwaysShulin Fu, Jingyang Li, Jiarui You, et al.
Veterinary Research|October 1, 2024
Correction: Baicalin attenuates PD-1/PD-L1 axis-induced immunosuppression in piglets challenged with Glaesserella parasuis by inhibiting the PI3K/ Akt/mTOR and RAS/MEK/ERK signalling pathwaysShulin Fu, Jingyang Li, Jiarui You, et al.
Pageof 17